These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12143054)

  • 1. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions.
    Endo K; Yoon BI; Pairojkul C; Demetris AJ; Sirica AE
    Hepatology; 2002 Aug; 36(2):439-50. PubMed ID: 12143054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets.
    Sirica AE; Lai GH; Endo K; Zhang Z; Yoon BI
    Semin Liver Dis; 2002 Aug; 22(3):303-13. PubMed ID: 12360423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma.
    Radaeva S; Ferreira-Gonzalez A; Sirica AE
    Hepatology; 1999 May; 29(5):1453-62. PubMed ID: 10216129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclooxygenase-1 and -2 in extra-hepatic cholangiocarcinoma.
    Wu GS; Wang JH; Liu ZR; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):429-33. PubMed ID: 14607721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.
    Hayashi N; Yamamoto H; Hiraoka N; Dono K; Ito Y; Okami J; Kondo M; Nagano H; Umeshita K; Sakon M; Matsuura N; Nakamori S; Monden M
    Hepatology; 2001 Oct; 34(4 Pt 1):638-50. PubMed ID: 11584358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
    Choi HJ; Kim HJ; Choi JH
    Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells.
    Nzeako UC; Guicciardi ME; Yoon JH; Bronk SF; Gores GJ
    Hepatology; 2002 Mar; 35(3):552-9. PubMed ID: 11870367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology.
    Baskin-Bey ES; Moreno Luna LE; Gores GJ
    J Hepatol; 2006 Oct; 45(4):476-9. PubMed ID: 16901574
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
    Maeda T; Taguchi K; Aishima S; Shimada M; Hintz D; Larusso N; Gores G; Tsuneyoshi M; Sugimachi K; Wands JR; de la Monte SM
    Cancer Detect Prev; 2004; 28(5):313-8. PubMed ID: 15542253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
    Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis.
    Terada T; Nakanuma Y; Sirica AE
    Hum Pathol; 1998 Feb; 29(2):175-80. PubMed ID: 9490278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis.
    Kim HJ; Lee KT; Kim EK; Sohn TS; Heo JS; Choi SH; Choi DI; Lee JK; Paik SW; Rhee JC
    J Gastroenterol Hepatol; 2004 May; 19(5):582-8. PubMed ID: 15086604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract.
    Chow NH; Huang SM; Chan SH; Mo LR; Hwang MH; Su WC
    Anticancer Res; 1995; 15(3):1055-9. PubMed ID: 7645925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different expression of cyclooxygenase-2 in biliary epithelia of bile duct cancer with or without pancreaticobiliary maljunction.
    Watanabe O; Yoshimatsu K; Shiozawa S; Tsuchiya A; Oshibe N; Aiba M; Ogawa K
    Anticancer Res; 2004; 24(2B):671-4. PubMed ID: 15161010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
    Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
    Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma.
    Schmitz KJ; Lang H; Wohlschlaeger J; Reis H; Sotiropoulos GC; Schmid KW; Baba HA
    Virchows Arch; 2007 Feb; 450(2):135-41. PubMed ID: 17165088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.
    Chariyalertsak S; Sirikulchayanonta V; Mayer D; Kopp-Schneider A; Fürstenberger G; Marks F; Müller-Decker K
    Gut; 2001 Jan; 48(1):80-6. PubMed ID: 11115827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
    Zheng J; Zhu YM
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.